is semaglutide for diabetes Type 2 diabetes: Ozempic and Wegovy improve blood sugar, weight loss Popular diabetes, weight loss drugs

Frank, P

David Macklin's weight management practice in Toronto, the name Ozempic is mentioned almost daily in appointments

Therapeutic potential of semaglutide, a newer GLP-1 receptor agonist, in abating obesity, non-alcoholic steatohepatitis and neurodegenerative diseases: A narrative review

At a glance GLP-1 medications are changing how consumers eat, with appetite suppression, smaller portions and altered taste preferences driving demand for nutrient-dense, high-protein foods Brands can lead through smarter reformulation, offering products fortified with protein, fiber and clean label sweeteners to help consumers stay nourished on fewer calories Improving nutrient density can drive opportunity high-protein, high fiber, portion-controlled foods and beverages align with new consumer priorities for long-term weight and wellness management Innovation spans multiple categories, with bakery, snacks and beverages being ideal platforms for nutrient-dense reformulations that balance functionality, taste and texture Ingredion's portfolio of resistant starches, prebiotic fibers, pulse proteins and low- and no-calorie sweeteners help formulators meet the evolving nutritional needs of consumers on GLP-1 based medications as well as those looking to manage their weight without pharmaceuticals Weight management trends are redefining nutrition and pushing brands to reformulate For food and beverage brands, this shift represents far more than a dietary trend

Online pharmacies are the fastest-growing channel, fueled by patient preference for home delivery, growing digital adoption, and affordable prices

Gastrointestinal Effects One of the most common side effects associated with GLP-1 medications is gastrointestinal discomfort, which can include nausea, vomiting, and diarrhea